Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)

NCT01006538 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

363

Enrollment

OTHER

Sponsor class

Conditions

Macular Degeneration

Interventions

DEVICE: Epimacular Brachytherapy
DRUG: Ranibizumab

Sponsor

King's College Hospital NHS Trust